The mechanisms by which blocking of the VEGF pathway and PD-1/PD-L1 axis may influence the biological profiles of PD-1, PD-L1, CD39, CD73, and A2AR in the tumor microenvironment are also unclear. Here, ADORA2A is linked to neoplasm.